It is widely accepted that reactive arthritis is associated with enthesitis. We recently saw a patient with chronic Achilles tendonitis who suVered a rupture of this tendon at the tendocalcaneal insertion.
A 22 year old male locksmith presented in December 1994 with bilateral metatarsalgia and right fourth toe dactylitis. Naproxyn was introduced with partial resolution of symptoms. In April 1995 he developed synovitis in the left knee, both ankles, and enthesitis in the right Achilles tendon, right posterior tibialis tendon, and bilateral plantar fascitis. There was no history of rash, inflammatory eye disease, back pain, gastroenteritis or genitourinary symptoms. Investigations revealed an erythrocyte sedimentation rate (ESR) of 25 mm 1st h, HLA B27 positive, increased serum IgM antibodies to Yersinia enterocolitica 05 (optical density 0.581) (Yersinia 03 and 09 negative) despite negative stool cultures and synovial fluid from the knee contained 10.9 × 10 9 white blood cells (80% neutrophils, Gram stain negative, culture negative and no crystals). A diagnosis of reactive arthritis presumably secondary to Yersinia enterocolitica was made. Indomethicin 50 mg thrice daily and sulphasalazine 1 g thrice daily were initially given. Because of continuing active disease with recurrent massive knee eVusions prednisone 20 mg in the morning and methotrexate 7.5 mg weekly were added and most of his symptoms improved, although clinically his right Achilles tendon was still troublesome. Prednisone was tapered. In October 1995 he presented with a flare up of disease (especially his right Achilles tendon) after an episode of gastroenteritis. On this occasion the ESR was 8 mm 1st h and repeat Yersinia enterocolitica 05 IgM serology had fallen (optical density 0.191), but stool cultures grew Campylobacter jejuni. He continued taking prednisone, sulphasalazine, and methotrexate and his joint symptoms improved. However clinically and symptomatically a low grade enthesitis continued in the right Achilles but local corticosteroid injections were not used.
In January 1996 when stepping out of a parked vehicle onto the right foot, he heard a 'snap' and suVered intense pain in the back of the heel. A clinical diagnosis of Achilles tendon rupture was made and surgical exploration and repair was undertaken. At operation rupture had occurred at the calcaneal insertion.
Despite the commonly recognised association of Achilles tendonitis with inflammatory arthritis surprisingly few reports of rupture have been recorded. Associated conditions include rheumatoid arthritis, 1 systemic lupus erythematosus, 2 3 and gout, 4 but no cases with reactive arthritis were found. Most patients had received oral or peritendon corticosteroids. There are a number of case reports where ruptured Achilles tendons have occurred with oral corticosteroids in patients with respiratory disease. 5 6 There were no case reports of ruptured Achilles tendons with sulphasalazine or methotrexate without concomittant oral or percutaneous corticosteroid therapy. The usual site of rupture of the Achilles tendon is 2-6 cm proximal to the calcaneal insertion. In this area there is a reduction in both the number and mean relative area of vessels. 7 In this case although the patient was taking prednisone, the rupture was at an unusual site-the tendocalcaneal insertion-suggesting that enthesitis had led to weakening of the tendon in this position. None of the previous reports have shown rupture at the tendocalcaneal insertion. It is interesting to speculate, that in this case suppressing inflammation by local corticosteroid infiltration around the Achilles tendon may have prevented rupture.
In summary we have reported a young man with a short history of reactive arthritis in which both yersinia and campylobacter have been implicated as triggering organisms. He required aggressive treatment with nonsteroidal anti-inflammatory drugs, oral corticosteroid, sulphasalazine, and methotrexate to control disease with the main symptomatic area being enthesitis of the Achilles tendon. He sustained a rupture of the Achilles tendon at the tendocalcaneal junction implicating enthesitis as the predisposing factor. Dactylitis also involving the synovial sheaths in the palm of the hand: two more cases studied by magnetic resonance imaging
We previously reported on the case of a 37 year old woman suVering from B27 positive psoriatic arthritis and showing dactylitis of the middle finger also involving the uncommon synovial sheaths communicating with the ulnar bursa. 1 The continuity of flexor synovial sheath involvement was shown by ultrasonography. We have recently seen two similar cases, which we studied by magnetic resonance imaging (MRI). One patient also had synovitis together with pitting oedema of the dorsum of the hand, which has been described in elderly patients with spondyloarthritis (SpA).
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The first patient was a 65 year old woman with a 20 year history of asymmetric erosive peripheral arthritis of the metatarsophalangeal, midfoot, hindfoot, radiocarpal, midcarpal, metacarpophalangeal (MTP), and proximal and distal hand interphalangeal joints and enthesitis of the quadriceps and patellar tendons on both patellae.
In October 1994 she was referred to us because of a reoccurrence of her peripheral arthritis in the right hand of two months' duration.
Her family history was negative for SpA and other B27 related diseases.
Physical examination showed dactylitis of the fourth right finger together with synovitis with a large pitting oedema of the dorsum of the right hand. The painful swelling of the synovial sheaths of the flexor tendons of the fourth finger extended as far as the palm of the hand.
HLA typing showed A24, A29, B27, DR7, DR11, DQ2, DQ7 antigens. Tests for the rheumatoid factor and the antinuclear antibodies were negative. Spinal and pelvic radiographs were normal.
MRI performed according to the methods previously described 6 showed flexor tenosynovitis of the right fourth finger extending without any interruption into the palm of the hand. On the dorsum of the hand oedema in the subcutaneous and peritendinous soft tissues and fluid in the extensor tendon synovial sheaths were observed (fig 1) .
The second patient, a 53 year old woman with a 12 year history of erosive asymmetric arthritis of the MTP joints, came to our unit in November 1995 showing dactylitis of the third right finger and planter fasciitis of the left foot.
Physical examination showed that the swelling and tenderness present along the flexor tendon course of the "sausage shaped" third right finger extended as far as the middle part of the palm of the hand. There was no limitation of spine movement and chest expansion.
Laboratory investigation showed negative tests for rheumatoid factor and antinuclear antibodies and A1, B8, B27, Cwl, Cw2, DR3, DR12, DQ2, DQ7 HLA antigens.
MRI showed fluid collection in the synovial flexor sheath of the third left finger continuing into the middle part of the hand (fig 2) . Spinal and sacroiliac joint radiography were normal.
Both our patients have a B27 positive undiVerentiated SpA. 4 7 During the course of the disease they developed a destructive peripheral arthritis, peripheral enthesitis, and dactylitis.
SpA dactylitis results from flexor tenosynovitis. 6 These two cases confirm our hypothesis that when flexor tenosynovitis involves a finger with synovial sheaths communicating with the ulnar palmocarpal sheaths, the sausage swelling also extends into the palm of the hand. Patient 1 also showed synovitis with pitting oedema of the dorsum of the hand, which has recently been described in elderly patients with SpA. [2] [3] [4] [5] The aspect of the inflammatory oedema in late onset SpA is similar to that seen in the RS3PE (remitting seronegative symmetrical synovitis with pitting oedema) syndrome 8 and in polymyalgia rheumatica. 9 Unlike RS3PE syndrome, the pitting oedema of late onset undiVerentiated SpA is usually unilateral and more frequent in the feet.
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Schaeverbeke et al have recently suggested that the oedema may be ascribed to an increase in capillary permeability as a result of focal inflammation. 5 The MRI findings in our patient confirm this hypothesis. The examination showed fluid in the subcutaneous and peritendinous soft tissues and inflammation of the extensor tendon synovial sheaths. Our cases suggest that the inflammatory oedema of the dorsum of hands and feet 
MATTERS ARISING

Pain in the rheumatic diseases
In their correspondence about pain in the rheumatic diseases, Thompson and Carr report that some of their cohort of 100 patients with inflammatory arthritis show a disassociation between reported pain and objective measures of disease activity. 1 In most patients there was a close linear relation between change of reported pain, the number of swollen joints, and C reactive protein over two years. However 18 patients reported high pain scores despite no evidence of C reactive protein or swollen joint activity. On the other hand 10 patients reported no pain despite active disease. The diVerence could not be explained on the grounds of joint deformity. Thompson and Carr do not set out to explain their finding.
Figure 1 Proton density axial section images at the middle of the palm of the hands showing the intense signal caused by fluid distending and encircling the right extensor (arrows) and IV flexor synovial sheaths (arrowheads). An overlaying subcutaneous and peritendinous soft tissue oedema is visible (white open arrow
However their previous writings on subjects such as handicap 2 indicate they are well aware of the importance of psychosocial factors in the manifestations of disease and, by implication, the weakness of rigid application of the medical model to chronic disease. Only a small proportion of patients with the mechanical low back pain or tender fibromyalgic spots develops chronic pain syndromes and becomes severely disabled. Psychosocial factors rather than clinical findings or treatment prescribed are the strongest predictors of chronicity in mechanical low back pain. 3 In patients with fibromyalgia WolV et al have demonstrated that the number of tender spots is proportional to the degree of distress. They suggest that the tender point count could be considered as the erythrocyte sedimentation rate of distress. 4 Even in osteoarthritis, disease severity accounts for only a proportion of the individual variability in clinical outcome. After controlling for disease severity, psychological variables remain strong predictors of individual diVerences in functional impairment and pain. 5 Thus it is well established that psychosocial factors are important predictors of ongoing pain in non-inflammatory musculoskeletal conditions. There is no reason to anticipate that people will behave diVerently whether responding to pain of an inflammatory or non-inflammatory nature. Thus it can be assumed that a proportion of those with rheumatoid arthritis will develop a chronic pain syndrome. This is almost certainly what has happened in the 18% of Thompson and Carr's patients with high pain scores in the presence of inactive disease.
The appropriate treatment of these patients is not by first, second or third line drugs combined or otherwise but by paying attention to self management strategies, coping skills, etc, etc. No doubt a proportion of those with active disease will also have developed chronic pain behaviours and associated disability that require as much attention as the raised C reative protein and number of swollen joints.
And what are we to make of the 10% of RA patients who do not express pain despite active disease? Although they are a delight for the rheumatologist to deal with, such pain related behaviour may also be pathological. 
Authors' reply
We agree with Dr Jones that psychological factors are likely to be important in self reported pain and disability in chronic musculoskeletal conditions. However, the available clinical data are controversial in this area. Current studies variously report an absent 1 or only weak 2 correlation between disease activity and pain scores, that disease activity is a strong predictor of pain 3 and that disease activity influences pain indirectly via depression. 4 Therefore we feel that the cause and eVect relation between psychosocial distress and self reported pain and disability remains a hypothesis that would explain our findings rather than a conclusion of the findings themselves.
We are currently studying these relations in more detail. What about IgA rheumatoid factor in rheumatoid arthritis?
We read with interest the editorial by Soltys and colleagues about rheumatoid factors (RFs). 1 They correctly stated that most naturally occurring RFs were of the IgM isotype while IgG RFs were thought to be associated with rhematoid arthritis (RA). It should be pointed out in this context that it is very difficult to measure IgG RF and this RF isotype can only be detected in approximately 50% of RA patients whereas IgA RF, usually in combination with IgM RF, can be detected in most patients with seropositive RA. [2] [3] [4] It should also be noted that increased IgA RF is associated with severe manifestations in RA and this has been extensively reported by several diVerent groups in the last 15 years. [5] [6] [7] [8] [9] [10] Furthermore, several reports have shown that RFs may be increased in serum many months or even years before clinical symptoms of RA appear, [11] [12] [13] and it has also been reported that symptom free people with an increase in IgA RF or IgG RF have an increased risk of developing RA. Recent studies have shown that a combined increase in IgM and IgA RF, with or without IgG RF, is the most common RF pattern found in patients with RA.
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Thus, a combined increase in IgM and IgA RF is very specific for RA and rarely found in symptom free people or patients with other rheumatic disorders. 3 15 It should also be noted that IgG RF and IgM RF are more frequently raised than IgA RF in symptom free members of families with multicase RA. 16 This indicates that an increase in IgA RF is more specific for RA than an increase in IgM RF or IgG RF. Thus, switching from IgM RF to IgA RF may be at least as important in the pathogenesis of RA as switching to the IgG class.
Several studies have shown that RA patients with an increase in IgA RF develop a more severe disease, with bone erosions or extra-articular manifestations, or both, than patients without IgA RF. 5-10 17-21 
